Diabetic Retinopathy
Conditions
Brief summary
The investigator study evaluate the effect of different lipid lowering agents on the progression of diabetic retinopathy and other reduction of cardiovascular risk of diabetic patients
Detailed description
The investigator study compare the effect of lipid lowering agent on the enhancement of visual acuity and on reduction of macular edema in patients with diabetic retinopathy and also compare their effect on reduction of cardiovascular risk on diabetic patients via assessment of ASCVD risk score
Interventions
DRUGSimvastatin 40mg
Drugs that lower lipid level
Drugs that lower lipid levels
DRUGOmega 3 fatty acid
Drugs that lower lipid levels
Sponsors
Alaa Hassan ElBaz
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* type 2diabetes * Non proliferative diabetic retinopathy
Exclusion criteria
* Uncontrolled glycemic level * proliferative diabetic retinopathy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The 80 participants will be evaluated through reduction of macular edema | 18 weeks | assessed by ocular coherence tomography |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The 80 participants will be evaluated through reduction of cardiovascular risk | 18 weeks | assessed by ASCVD risk score |
Outcome results
None listed